An earlier study reported that the lp-PLA2 inhibitor, darapladib, reduces complex coronary atherosclerotic plaque development in pigs with induced diabetes and hypercholesterolemia [7]. This evidence concerns the gene PLA2G7 and Hypercholesterolemia.